
Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.
Citing sources familiar with the matter, Bloomberg noted that the longest tranche of the sale —a 12-year security —could yield about one percentage point above Treasuries.